G. Johnsson

3.5k total citations
82 papers, 2.9k citations indexed

About

G. Johnsson is a scholar working on Analytical Chemistry, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, G. Johnsson has authored 82 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Analytical Chemistry, 27 papers in Cardiology and Cardiovascular Medicine and 19 papers in Pharmacology. Recurrent topics in G. Johnsson's work include Analytical Methods in Pharmaceuticals (29 papers), Pharmacology and Obesity Treatment (12 papers) and Blood Pressure and Hypertension Studies (11 papers). G. Johnsson is often cited by papers focused on Analytical Methods in Pharmaceuticals (29 papers), Pharmacology and Obesity Treatment (12 papers) and Blood Pressure and Hypertension Studies (11 papers). G. Johnsson collaborates with scholars based in Sweden, Switzerland and United Kingdom. G. Johnsson's co-authors include C G Regårdh, B. Edgar, Bengt Åblad, Carl‐Gunnar Regårdh, Jonas Lundahl, Lennart Sölvell, K. O. Borg, Per Lundborg, Calle Bengtsson and C. G. Reg�rdh and has published in prestigious journals such as European Heart Journal, The American Journal of Cardiology and Life Sciences.

In The Last Decade

G. Johnsson

80 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Johnsson Sweden 33 1.0k 578 553 487 414 82 2.9k
Richard I. Ogilvie Canada 30 878 0.9× 494 0.9× 327 0.6× 742 1.5× 407 1.0× 112 3.9k
M. J. Kendall United Kingdom 29 497 0.5× 300 0.5× 280 0.5× 401 0.8× 214 0.5× 127 2.4k
P. van Brummelen Netherlands 36 1.5k 1.5× 410 0.7× 248 0.4× 365 0.7× 692 1.7× 136 3.9k
Robert E. Kates United States 33 1.8k 1.7× 276 0.5× 493 0.9× 336 0.7× 590 1.4× 92 3.0k
JL Reid United Kingdom 33 1.5k 1.5× 198 0.3× 395 0.7× 327 0.7× 781 1.9× 166 3.6k
Thomas E. Gaffney United States 27 626 0.6× 263 0.5× 235 0.4× 226 0.5× 355 0.9× 55 1.9k
C G Regårdh Sweden 28 506 0.5× 798 1.4× 370 0.7× 468 1.0× 438 1.1× 59 2.8k
Hermann R. Ochs United States 30 582 0.6× 553 1.0× 265 0.5× 497 1.0× 366 0.9× 117 2.8k
K O'Malley Ireland 35 1.7k 1.7× 376 0.7× 118 0.2× 369 0.8× 438 1.1× 144 4.0k
J. L. McNay United States 27 1.1k 1.1× 255 0.4× 139 0.3× 268 0.6× 533 1.3× 93 3.1k

Countries citing papers authored by G. Johnsson

Since Specialization
Citations

This map shows the geographic impact of G. Johnsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Johnsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Johnsson more than expected).

Fields of papers citing papers by G. Johnsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Johnsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Johnsson. The network helps show where G. Johnsson may publish in the future.

Co-authorship network of co-authors of G. Johnsson

This figure shows the co-authorship network connecting the top 25 collaborators of G. Johnsson. A scholar is included among the top collaborators of G. Johnsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Johnsson. G. Johnsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Johnsson, G., et al.. (2006). Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin Inhibitor Ximelagatran in Young Healthy Japanese Men. Clinical Pharmacokinetics. 45(1). 77–84. 2 indexed citations
3.
Lundahl, Jonas, C G Regårdh, B. Edgar, & G. Johnsson. (1998). The interaction effect of grapefruit juice is maximal after the first glass. European Journal of Clinical Pharmacology. 54(1). 75–81. 43 indexed citations
4.
Lundahl, Jonas, C. G. Reg�rdh, B. Edgar, & G. Johnsson. (1995). Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects. European Journal of Clinical Pharmacology. 49(1-2). 61–7. 106 indexed citations
5.
Edgar, B., et al.. (1993). The acute haemodynamic and renal effects of oral felodipine and ramipril in healthy subjects. European Journal of Clinical Pharmacology. 45(4). 327–32. 5 indexed citations
6.
Johnsson, G.. (1990). Summary of Session IV. The Journal of Clinical Pharmacology. 30(S2). 1 indexed citations
7.
Edgar, B., et al.. (1989). Pharmacokinetics of felodipine in patients with impaired renal function.. British Journal of Clinical Pharmacology. 27(1). 67–74. 23 indexed citations
8.
Edgar, B., Mattias Aurell, G. Johnsson, C G Regårdh, & Charles W. Shansky. (1987). Effects of Impaired Renal Function on the Pharmacokinetics of Felodipine. Drugs. 34(Supplement 3). 31–32. 4 indexed citations
9.
Jordö, L., G. Johnsson, Per Lundborg, & C G Regårdh. (1984). Pharmacokinetics of lidocaine in healthy individuals pretreated with multiple doses of metoprolol.. PubMed. 22(6). 312–5. 5 indexed citations
10.
Johnsson, G., Gordon Murray, A. C. Tweddel, & I. Hutton. (1983). Haemodynamic effects of a new vasodilator drug, felodipine, in healthy subjects. European Journal of Clinical Pharmacology. 24(1). 49–53. 50 indexed citations
11.
Johnsson, G., et al.. (1977). Bioavailability of quinidine in slow-release form. A comparison between two preparations containing quinidine bisulphate as the active constituent.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 27(9). 1716–1718. 1 indexed citations
12.
Johnsson, G. & CG Regardh. (1976). Clinical Pharmacokinetics of β-Adrenoreceptor Blockers. Drugs. 11(Supplement 1). 111–121. 16 indexed citations
13.
Bengtsson, Calle, G. Johnsson, R Sannerstedt, & Lars Werkö. (1975). Effect of different doses of chlorthalidone on blood pressure, serum potassium, and serum urate.. BMJ. 1(5951). 197–199. 58 indexed citations
14.
Åblad, Bengt, K. O. Borg, Enar Carlsson, et al.. (1975). A survey of the pharmacological properties of metoprolol in animals and man. Acta Pharmacologica et Toxicologica. 36(s5). 7–23. 126 indexed citations
15.
Boeryd, B, et al.. (1975). Alteration of metastases distribution by vaso-dilating drugs.. PubMed. 10(3). 197–201. 3 indexed citations
16.
Boeryd, B, et al.. (1974). Effects of EACA, AMCHA and guanethidine on metastases induced by intravenously injected tumour cells.. PubMed. 9(2). 119–23. 4 indexed citations
17.
Johnsson, G.. (1974). ALPRENOLOL IN HYPERTENSION. Acta Medica Scandinavica. 195(S554). 5–7. 5 indexed citations
18.
Carlsson, C., et al.. (1971). Effects on haemodynamics and plasma noradrenaline levels in man of long term treatment with imipramine, haloperidol and chlorpromazine. European Journal of Clinical Pharmacology. 3(3). 163–171. 1 indexed citations
19.
Johnsson, G.. (1967). Comparative Effects of Intra‐arterially Administered Isoprenaline and Sodium Nitrite on Blood Flow and Volume of the Forearm. Acta Pharmacologica et Toxicologica. 25(4). 385–396. 26 indexed citations
20.
Åblad, Bengt, G. Johnsson, & M. Henning. (1962). The Effects of Hydralazine Administered into the Brachial Artery on Adrenergic Vasoconstrictor Stimuli in the Hand. Acta Pharmacologica et Toxicologica. 19(2). 165–180. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard I. Ogilvie Breakdown of academic impact, for papers by M. J. Kendall Breakdown of academic impact, for papers by P. van Brummelen Breakdown of academic impact, for papers by Robert E. Kates Breakdown of academic impact, for papers by JL Reid Breakdown of academic impact, for papers by Thomas E. Gaffney Breakdown of academic impact, for papers by C G Regårdh Breakdown of academic impact, for papers by Hermann R. Ochs Breakdown of academic impact, for papers by K O'Malley Breakdown of academic impact, for papers by J. L. McNay
Rankless by CCL
2026